https://sputnikglobe.com/20200716/ottawa-working-with-beijing-to-begin-testing-of-chinese-covid-19-vaccine-trudeau-says-1079907888.html
Ottawa Working With Beijing To Begin Testing of Chinese COVID-19 Vaccine, Trudeau Says
Ottawa Working With Beijing To Begin Testing of Chinese COVID-19 Vaccine, Trudeau Says
Sputnik International
TORONTO (Sputnik) - Ottawa is working with Beijing to facilitate the start of testing of a Chinese vaccine candidate against the novel coronavirus disease in... 16.07.2020, Sputnik International
2020-07-16T22:55+0000
2020-07-16T22:55+0000
2022-08-06T13:35+0000
https://cdn1.img.sputnikglobe.com/img/07e4/07/10/1079907840_0:0:3072:1738_1920x0_80_0_0_a8db45a76a026e5081566c93eeb05670.jpg
china
canada
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2020
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
newsfeed, china, coronavirus, justin trudeau, canada
newsfeed, china, coronavirus, justin trudeau, canada
Ottawa Working With Beijing To Begin Testing of Chinese COVID-19 Vaccine, Trudeau Says
22:55 GMT 16.07.2020 (Updated: 13:35 GMT 06.08.2022) TORONTO (Sputnik) - Ottawa is working with Beijing to facilitate the start of testing of a Chinese vaccine candidate against the novel coronavirus disease in Canada, Prime Minister Justin Trudeau said during a briefing.
Chinese biotechnology firm, CanSino Biologics Inc. (CanSinoBIO), received Canadian regulatory approval to begin testing in Canada in May but the process has been reportedly delayed by China’s customs authorities.
“We’re obviously continuing to work with the Chinese government to ensure that this work can continue in an uninterrupted fashion,” Trudeau said on Thursday.
There are also reports that Russia is among the countries being considered for CanSinoBIO’s COVID-19 vaccine phase III testing.
The Ad5-nCoV candidate was developed in a joint venture by CanSinoBIO and the Chinese military’s Academy of Military Medical Sciences.
Canadian Prime Minister Justin Trudeau has repeatedly stressed the daily constraints that much of the population is adhering to will be the new normal until a vaccine is developed.
